Annual Report 2021

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2021 126 The United Laboratories International Holdings Limited Annual Report 2021 31. SHARE CAPITAL (Continued) During the current year, the Company repurchased its own ordinary shares through the Stock Exchange as follows: Month of repurchase No. of ordinary shares of HK$0.01 each Price per share Aggregate consideration paid Highest Lowest HK$ HK$ HK$’000 Dec 2021 10,900,000 4.600 4.460 49,869 RMB’000 Shown in the consolidated financial statements as: At 31 December 2021 40,978 6,184,000 ordinary shares were cancelled upon repurchase. The remaining 4,716,000 ordinary shares have not yet been cancelled as at 31 December 2021 and therefore classified as treasury stocks. None of the Company’s subsidiaries purchased, sold or redeemed any of the Company’s listed securities during the year.